Healthcare & Pharmaceuticals Blog
- Blog: Haynes and Boone BlogsIRS and Treasury Issue Proposed Regulations Under Code Section 162(m)Posted on January 3, 2020 by Haynes and Boone Benefits GroupThe IRS and Treasury recently issued proposed regulations under Internal Revenue Code Section 162(m) to reflect changes enacted by the Tax Cuts and Jobs Act (“TCJA”) to the tax deductibility of compensation paid by publicly held corporations to certain executive officers. Code Section 162(m) disallows the deduction by any publicly held corporation for compensation paid […] The post IRS and Treasury Issue Proposed Regulations Under Code Section 162(m) appeared first on Haynes and Boone Blogs.
- Blog: Biologics BlogFederal Circuit Clarifies Limits of Safe Harbor Defense in Amgen v. HospiraPosted on January 2, 2020 by Recently, in Amgen Inc. v. Hospira, Inc., the Federal Circuit clarified the limits of the Safe Harbor defense in cases involving patented manufacturing methods. In a case brought in the District of Delaware, Amgen alleged that Hospira infringed several patent claims over methods of manufacturing erythropoietin (EPO), a biologic drug used to treat anemia. Following [...]